Canopy Growth Corp (TSE:WEED) has earned an average recommendation of “Buy” from the eleven ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is C$72.73.
A number of brokerages have commented on WEED. Bank of America restated a “buy” rating and issued a C$70.00 target price on shares of Canopy Growth in a research note on Wednesday, April 17th. CIBC lifted their target price on Canopy Growth from C$75.00 to C$80.00 in a research note on Monday, April 22nd. Bryan, Garnier & Co downgraded Canopy Growth from a “buy” rating to a “neutral” rating and decreased their target price for the company from C$85.00 to C$60.00 in a research note on Thursday, July 4th. Cormark decreased their target price on Canopy Growth from C$70.00 to C$65.00 in a research note on Monday, June 24th. Finally, Desjardins decreased their target price on Canopy Growth from C$63.00 to C$59.00 and set a “hold” rating for the company in a research note on Thursday, July 4th.
WEED stock traded up C$1.26 during midday trading on Friday, reaching C$42.60. The company had a trading volume of 1,591,297 shares, compared to its average volume of 2,577,453. The company has a debt-to-equity ratio of 13.06, a current ratio of 12.32 and a quick ratio of 11.30. The stock’s 50 day moving average price is C$50.09. Canopy Growth has a fifty-two week low of C$32.01 and a fifty-two week high of C$76.68. The stock has a market cap of $14.17 billion and a price-to-earnings ratio of -16.58.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Further Reading: What is the downside to momentum investing?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.